海尔生物合并“血王”计划折戟

华尔街见闻
Jan 07, 2025

作者 | 黄昱编辑 | 刘宝丹短短15天过去,海尔欲整合海尔生物和“血王”上海莱士的计划就折戟了。1月6日晚,海尔集团旗下海尔生物(688139.SH)与上海莱士(002252.SZ)发布关于终止筹划重大资产重组暨公司股票复牌公告,终止筹划海尔生物吸收合并上海莱士的重大资产重组事项。对此,海尔大健康业务板块盈康一生对华尔街见闻表示,由于本次交易结构较为复杂,尚未能形成相关各方认可的具体方案。经审慎...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10